Evidence map›Paper›PMID 37668694›Full record

ArticleEuropean radiology2024

Head to head comparison of

Annan Zhang, Xiangxi Meng, Yuan Yao, Xin Zhou, Yan Zhang, Nan Li

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Annan ZhangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, 52 Fucheng Road, Haidian, Beijing, 100142, China.
Xiangxi MengKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, 52 Fucheng Road, Haidian, Beijing, 100142, China.
Yuan YaoKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, 52 Fucheng Road, Haidian, Beijing, 100142, China.
Xin ZhouKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, 52 Fucheng Road, Haidian, Beijing, 100142, China.
Yan ZhangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, 52 Fucheng Road, Haidian, Beijing, 100142, China.
Nan LiKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, 52 Fucheng Road, Haidian, Beijing, 100142, China. rainbow6283@sina.com.ORCID http://orcid.org/0000-0001-8619-7550
Peking University · CN

Funding

National Natural Science Foundation of China 81871387Natural Science Foundation of Beijing Municipality 7202027
6 · The paper itself

Abstract

objectiveWe conducted a prospective study using

methodsFifty-four participants were undergoing

resultsFifty-four participants were confirmed to have 71 primary lesions, 56 metastatic lymph nodes, and 43 metastatic lesions.

conclusionCLINICAL RELEVANCE STATEMENT: The application of KEY POINTS: •

Indexed as

Heterocyclic Compounds, 1-RingLiver NeoplasmsPositron Emission Tomography Computed TomographyQuinolinesFluorodeoxyglucose F18Gallium RadioisotopesHumansLymphatic MetastasisProspective StudiesThorax1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid68Ga-FAPIFluorodeoxyglucose F18Gallium RadioisotopesHeterocyclic Compounds, 1-RingQuinolines18F-FDG68Ga-FAPIExtrapulmonary tumorsPET/CTSUV

Identifiers

PMID37668694
OpenAlexW4386438228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.